Skip to main content

Table 2 The univariate analysis for recurrence in MTC patients

From: Ultrasound features of medullary thyroid cancer as predictors of biological behavior

Variable N Recurrence P
No Yes
Age (years)   49.5 ± 12.1 53.4 ± 9.3 0.266a
Preoperative Ct/tumor size (pg/mL/mm)   32.15 51.68 0.002b
Gender     0.768
 Female 38 31 (54.4) 7 (50.0)  
 Male 33 26 (45.6) 7 (50.0)  
Tumor size (cm)   1.48 ± 0.96 1.81 ± 1.11 0.271
  ≤ 1 30 26 (45.6) 4 (28.6) 0.247
 >1 41 31 (54.4) 10 (71.4)  
Multifocality     0.917
 Yes 22 17 (29.8) 5 (35.7)  
 No 49 40 (70.2) 9 (64.3)  
Extrathyroid extension     0.047
 Yes 39 28 (49.1) 11 (78.6)  
 No 32 29 (50.9) 3 (21.4)  
Central node metastasisc     0.000
 Yes 30 18 (32.7) 12 (85.7)  
 No 39 37 (67.3) 2 (14.3)  
Lateral node metastasisd     1.000
 Yes 26 18 (78.3) 8 (72.7)  
 No 8 5 (21.7) 3 (27.3)  
T stage     0.166
 T1 + T2 32 28 (49.1) 4 (28.6)  
 T3 + T4 39 29 (50.9) 10 (71.4)  
N stage     0.003
 N0 33 32 (56.1) 1 (7.1)  
 N1a 12 7 (12.3) 5 (35.7)  
 N1b 26 18 (31.6) 8 (57.1)  
Preoperative Ct level (pg/mL)     0.009
  ≤ 100 16 16 (28.1) 0 (0.0)  
 100–1000 31 25 (43.9) 6 (42.9)  
  > 1000 24 16 (28.1) 8 (57.1)  
Biochemical curee     0.000
 Yes 39 37 (78.7) 2 (15.4)  
 No 21 10 (21.3) 11 (84.6)  
Classification of TI-RADS     0.013
  l-MTC 22 22 (38.6) 0 (0.0)  
 m-MTC 49 35 (61.4) 14 (100.0)  
  1. at test; b Mann-Whitney U test; c 2 patients underwent thyroidectomy without lymph node dissection; d Only 38 patients were performed lateral lymph node dissection; e Postoperative serum Ct is available in 63 cases,and 3 of these patients had underwented palliative surgery